These results could be explained by the absence of concomitant amplification or copy number gains of CCND1 and CCNE2 in our chordoma PDXs models (35), both of which are involved in RB inactivation driving tumor cells through the S phase (47). The gene discussed is CCND1; the disease is chordoma.